AGP Picks
View all

Perspectify logo Perspectify News

Labels

Read articles from across the media landscape with news outlet bias labels for added context. Learn about labels.

Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate Press Release Service
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Press Release Service
WHO sets out concerns over US vaccine trial in G.Bissau

WHO sets out concerns over US vaccine trial in G.Bissau

WHO chief slams 'unethical' US vaccine trial in G. Bissau
When Feed the Future shut down, these researchers built something new

When Feed the Future shut down, these researchers built something new

The fight against hepatitis in Africa hangs in the balance after US cuts: Clinics closed, fewer tests and canceled research

The fight against hepatitis in Africa hangs in the balance after US cuts: Clinics closed, fewer tests and canceled research

CDC to Conduct Hepatitis B Vaccine Trial in Guinea-Bissau, Raising Ethical Concerns

CDC to Conduct Hepatitis B Vaccine Trial in Guinea-Bissau, Raising Ethical Concerns

Why US-funded vaccine trial plan for babies in Guinea-Bissau caused outrage

Why US-funded vaccine trial plan for babies in Guinea-Bissau caused outrage

South Sudan passport ranks 50th in Africa

South Sudan passport ranks 50th in Africa

Statement on the planned hepatitis B birth dose vaccine trial in Guinea-Bissau

Statement on the planned hepatitis B birth dose vaccine trial in Guinea-Bissau

The Trump admin keeps citing unreviewed vaccine trial proposals in its call for ‘better science’

The Trump admin keeps citing unreviewed vaccine trial proposals in its call for ‘better science’

Outrage of the Month: CDC Funding of a Troubling Guinea-Bissau Hepatitis B Vaccine Study

Outrage of the Month: CDC Funding of a Troubling Guinea-Bissau Hepatitis B Vaccine Study

‘Not Reliable’: HHS Keeps Citing Unreviewed Vaccine Trial Proposals in Its Call for ‘Better Science’

‘Not Reliable’: HHS Keeps Citing Unreviewed Vaccine Trial Proposals in Its Call for ‘Better Science’

Cops raid office of RFK Jr. allies planning “unethical” vaccine trial on babies

Cops raid office of RFK Jr. allies planning “unethical” vaccine trial on babies

Opinion: When will we stop using Black bodies as research subjects?

Opinion: When will we stop using Black bodies as research subjects?

U.S. health research project rejected by Guinea-Bissau was deadly anti-vaccine scheme

U.S. health research project rejected by Guinea-Bissau was deadly anti-vaccine scheme

US-funded Guinea-Bissau vaccine study to undergo ethical review, Africa CDC official says

US-funded Guinea-Bissau vaccine study to undergo ethical review, Africa CDC official says

US-backed hepatitis B vaccine study halted in Guinea-Bissau

US-backed hepatitis B vaccine study halted in Guinea-Bissau

The slow death of American science

The slow death of American science

Fifth Ship Suffers Drone Attack in Bulgaria's Exclusive Economic Zone, Opposition Slams Government's Reaction

Fifth Ship Suffers Drone Attack in Bulgaria's Exclusive Economic Zone, Opposition Slams Government's Reaction

‘It’s the sovereignty of the country’: Guinea-Bissau says US vaccine study suspended

‘It’s the sovereignty of the country’: Guinea-Bissau says US vaccine study suspended

LRA Welcomes ECOWAS Parliament Oversight Mission on Regional Transit System

LRA Welcomes ECOWAS Parliament Oversight Mission on Regional Transit System

Sign up for:

Guinea Bissau Tech Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Guinea Bissau Tech Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.